Disease: Mucormycosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026718
Disease: Mucormycosis
Mucormycosis 		0.020 Biomarker disease BEFREE The results of two main clinical studies have led to an approval by FDA and EMA in the treatment of invasive aspergillosis and invasive mucormycosis. 29551442 2018
CUI: C0026718
Disease: Mucormycosis
Mucormycosis 		0.020 Biomarker disease BEFREE Isavuconazole is the most recent triazole compound, approved in 2015 by the FDA and the EMA to treat invasive aspergillosis and mucormycosis. 29534853 2018